Showing results (1881-1890 of 1,990) with videos related to
Sort By:
Pageof 199
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|May 23, 2021
Thymomectomy plus total thymectomy versus simple thymomectomy for early-stage thymoma without myasthenia gravis: a European Society of Thoracic Surgeons Thymic Working Group StudyFrancesco Guerrera, Pierre Emmanuel Falcoz, Bernhard Moser, et al.The European Respiratory Journal|September 7, 2010
Composite anatomical-clinical-molecular prognostic model in non-small cell lung cancerA López-Encuentra, F López-Ríos, E Conde, et al.Oncotarget|August 18, 2016
TP53 mutated glioblastoma stem-like cell cultures are sensitive to dual mTORC1/2 inhibition while resistance in TP53 wild type cultures can be overcome by combined inhibition of mTORC1/2 and Bcl-2Subramanian Venkatesan, Marlous Hoogstraat, Ester Caljouw, et al.The Science of the Total Environment|March 18, 2019
Unusual winter Saharan dust intrusions at Northwest Spain: Air quality, radiative and health impactsF Oduber, A I Calvo, C Blanco-Alegre, et al.Journal of Medicinal Chemistry|March 10, 2022
Discovery and In Vivo Proof of Concept of a Highly Potent Dual Inhibitor of Soluble Epoxide Hydrolase and Acetylcholinesterase for the Treatment of Alzheimer's DiseaseSandra Codony, Caterina Pont, Christian Griñán-Ferré, et al.Journal of Neuroinflammation|May 26, 2016
Inflammatory profile in LRRK2-associated prodromal and clinical PDKathrin Brockmann, Anja Apel, Claudia Schulte, et al.Frontiers in Cellular and Infection Microbiology|March 4, 2025
Immunological memory to COVID-19 vaccines in immunocompromised and immunocompetent childrenConstanza Russo, Adrián Otero, Macarena Uranga, et al.The Journal of Infectious Diseases|February 2, 2023
Incidence and Predictors of Breakthrough and Severe Breakthrough Infections of SARS-CoV-2 After Primary Series Vaccination in Adults: A Population-Based Survey of 22 575 ParticipantsStacia M DeSantis, Ashraf Yaseen, Tianyao Hao, et al.The Lancet. Oncology|July 6, 2023
γ-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, first-in-human trialAndrew J Cowan, Margot J Pont, Blythe D Sather, et al.Leukemia Research|March 7, 2003
A randomized study comparing interferon (IFN alpha) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia (CML)T Kühr, S Burgstaller, U Apfelbeck, et al.Pageof 199